BCLS Acquisition Corp.
Status: Liquidated
U=S
IPO Proceeds, $M | $143.75M |
---|---|
IPO Date | Oct 22, 2020 |
CEO | Jeffrey Schwartz |
Left Lead | Goldman Sachs |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector | Healthcare |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Closing Date | Oct 26, 2022 |
BLSA
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on BCLS Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 5 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Adam Koppel | 50 | Chairman |
Jeffrey Schwartz | 41 | Chief Executive Officer and Director |
Andrew Hack | 47 | Chief Financial Officer and Director |
Allene Diaz | 56 | Director |
Barry Greene | 57 | Director |
Vikas Sinha | 57 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Goldman Sachs | Joint BR | 6,250,000 | units |
Jefferies | Joint BR | 6,250,000 | |
12,500,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 5 filings.